Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48M
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
290K
-
Shares change
-
-132K
-
Total reported value, excl. options
-
$566K
-
Value change
-
-$196K
-
Number of buys
-
2
-
Number of sells
-
-5
-
Price
-
$1.95
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q2 2015
10 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q2 2015.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 290K shares
of 48M outstanding shares and own 0.6% of the company stock.
Largest 10 shareholders include CREDIT SUISSE AG/ (221K shares), BlackRock Institutional Trust Company, N.A. (33K shares), VANGUARD GROUP INC (26.6K shares), PERKINS CAPITAL MANAGEMENT INC (10K shares), AMERICAN INTERNATIONAL GROUP INC (5 shares), Tower Research Capital LLC (TRC) (0 shares), Verition Fund Management LLC (0 shares), KCG Holdings, Inc. (0 shares), Citadel Advisors LLC (0 shares), and UBS Group AG (0 shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.